Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Skin Neoplasms × Imiquimod × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 21 Carcinoma, Basal Cell 10 Uterine Cervical Dysplasia 7 Melanoma 6 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Precancerous Conditions 3 Glioblastoma 3 Condylomata Acuminata 3 Urinary Bladder Neoplasms 2 Squamous Intraepithelial Lesions 2 Papillomavirus Infections 2 Non-Muscle Invasive Bladder Neoplasms 2 Keratosis 2 Hutchinson's Melanotic Freckle 2 HIV Infections 2 Glioma 2 Astrocytoma 2 Warts 1 Vulvar Neoplasms 1 Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1 Virus Diseases 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sialorrhea 1 Sexually Transmitted Diseases 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Satisfaction 1

Interventions

aldesleukin 8 Interleukin-2 8 Dacarbazine 6 fludarabine phosphate 5 Cyclophosphamide 5 fludarabine 4 Temozolomide 4 Nivolumab 4 Ipilimumab 4 montanide ISA 51 3 Surveys and Questionnaires 3 Semaxinib 3 Radiotherapy 3 Radiation 3 Fluorouracil 3 Educational Status 3 Cisplatin 3 zanolimumab 2 talabostat 2 sonidegib 2 poly ICLC 2 binimetinib 2 Whole-Body Irradiation 2 Vinblastine 2 Vemurafenib 2 Tablets 2 Surgical Procedures, Operative 2 Spectrum Analysis, Raman 2 Sodium Chloride 2 Photochemotherapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03534947 2025-12-16

SONIB

Melanoma Institute Australia

Phase 2 Completed

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡